Ä¿¹Â´ÏƼ

¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÀÚ·á½Ç

ÀÚ·á½Ç

¹øÈ£ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏÀÚ Á¶È¸¼ö
°øÁö Licence in, out , sales service °ü¸®ÀÚ 2024-07-09 19
°øÁö FDA ÄÁ¼³ÆÃ, ¹Ì±¹ ÁøÃâ ½ÃÀåÁ¶»ç, Áö¿ø µå¸³´Ï´Ù. °ü¸®ÀÚ 2023-03-27 96
°øÁö EU Regulatory MDD ¿¡¼­ MDR, IVDR Àüȯ¿¡ µû¸¥ Clinical trialÀ» Æ÷ÇÔÇÑ Áö¿ø¹× Áغñ.. °ü¸®ÀÚ 2023-03-27 74
10 ADC CDMO Service(US FDA,EU EMA, PDMA, NMDA) °ü¸®ÀÚ 2024-07-02 26
9 Medical related area, Refer to reference (Notice) °ü¸®ÀÚ 2024-03-14 72
8 diagnostics test °ü¸®ÀÚ 2023-04-02 92
7 ÇØ¿ÜÀÓ»ó, µî·Ï °í·Á»çÇ×¹× ÁøÇà¹æÇâ (Clinical trial, registration capability For .. °ü¸®ÀÚ 2023-03-13 81
6 identification of unknown impurities, QC/batch release, etc °ü¸®ÀÚ 2022-11-11 82
5 Formulation manufacturer applications °ü¸®ÀÚ 2022-11-11 72
4 Therapeutic area focused examples °ü¸®ÀÚ 2022-11-11 67